Opportunities and challenges of developing thermostable vaccines

References

• Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine25(4), 691–697 (2007).
   PubMed Web of Science ®Google Scholar
• Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine25(20), 3980–3986 (2007).
   PubMed Web of Science ®Google Scholar
• Chen D, Tyagi A, Carpenter J et al. Characterization of the freeze sensitivity of a hepatitis B vaccine. Hum. Vacc.5(1), 1–7 (2009).
   Google Scholar
• Edstam JS, Dulmaa N, Tsendjav O, Dambasuren B, Densmaa B. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev. Med.39(2), 384–388 (2004).
   PubMed Web of Science ®Google Scholar
• Edstam JS, Dulmaa N, Nymadawa P et al. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev. Med.34(2), 207–214 (2002).
   PubMed Web of Science ®Google Scholar
• Levin A, Levin C, Kristensen D, Matthias D. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh. Vaccine25(39–40), 6945–6957 (2007).
   PubMed Web of Science ®Google Scholar
• Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm.185(2), 129–188 (1999).
   PubMed Web of Science ®Google Scholar
• Burke CJ, Hsu TA, Volkin DB. Formulation, stability, and delivery of live attenuated vaccines for human use. Crit. Rev. Ther. Drug Carrier Syst.16(1), 1–83 (1999).
   PubMed Web of Science ®Google Scholar
• Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR. A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. Vaccine24(31–32), 5839–5851 (2006).
   PubMed Web of Science ®Google Scholar
• Ausar SF, Espina M, Brock J et al. High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles. Hum. Vacc.3(3), 94–103 (2007).
   PubMed Web of Science ®Google Scholar
• Kissmann J, Ausar S, Rudolph A et al. Stabilization of measles virus for vaccine formulation. Hum. Vacc.4(5), 350–359 (2008).
   PubMed Web of Science ®Google Scholar
• Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. Preformulation studies of Clostridium difficile toxoids A and B. J. Pharm. Sci.97(10), 4194–4207 (2008).
   PubMed Web of Science ®Google Scholar
• Colin R, Gardner CR, Almarsson O et al. Application of high-throughput technologies to drug substance and drug product development. Comp. Chem. Engin.28(6–7), 943–953 (2004).
   Web of Science ®Google Scholar
• Jones-Braun L, Tyagi A, Perkins S et al. Polyols to prevent freeze–thaw damage to vaccines containing an aluminium salt adjuvant. Vaccine (2008) (Epub ahead of print).
   Google Scholar
• Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J. Biol. Chem.278(29), 26458–26465 (2003).
   PubMed Web of Science ®Google Scholar
• Cicerone MT, Soles CL. Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol. Biophys. J.86(6), 3836–3845 (2004).
   PubMed Web of Science ®Google Scholar
• Crowe JH, Carpenter JF, Crowe LM. The role of vitrification in anhydrobiosis. Ann. Rev. Phys.60, 73–103 (1998).
   PubMed Web of Science ®Google Scholar
• Franks F. Freeze-drying of bioproducts: putting principles into practice. Eur. J. Pharm. Biopharm.45(3), 221–229 (1998).
   PubMed Web of Science ®Google Scholar
• Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim. Biophys. Acta1468, 127–138 (2000).
   PubMed Web of Science ®Google Scholar
• Pisal S, Wawde G, Salvankar S, Lade S, Kadam S. Vacuum foam drying for preservation of LaSota virus: effect of additives. AAPS Pharm. Sci. Tech.7(3), 60 (2006).
   PubMedGoogle Scholar
• Wong Y, Sampson S, Germishuizen WA et al. Drying a tuberculosis vaccine without freezing. Proc. Natl Acad. Sci. USA.104(8), 2591–2595 (2007).
   PubMed Web of Science ®Google Scholar
• Runyan CM, Carmen JC, Beckstead BL et al. Low-frequency ultrasound increases outer membrane permeability of Pseudomonas aeruginosa.J. Gen. Appl. Microbiol.52(5), 295–301 (2006).
   PubMed Web of Science ®Google Scholar
• Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med. Biol.30(4), 519–526 (2004).
   PubMed Web of Science ®Google Scholar
• Shi X, Karkut T, Alting-Mees M et al. Enhancing Escherichia coli electrotransformation competency by invoking physiological adaptations to stress and modifying membrane integrity. Anal. Biochem.320(1), 152–155 (2003).
   PubMed Web of Science ®Google Scholar
• Hutubessy R, Chisholm D, Edejer T. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff. Resour. Alloc.1(1), 8 (2003).
   PubMedGoogle Scholar
• Van Damme P, Cramm M, Safary A, Vandepapelière P, Meheus A. Heat stability of a recombinant DNA hepatitis B vaccine. Vaccine.10(6), 366–367 (1992).
   PubMed Web of Science ®Google Scholar
• Hipgrave DB, Maynard JE, Biggs B. Improving birth dose coverage of hepatitis B vaccine. Bull. World Health Organ.84(1), 65–71 (2006).
   PubMed Web of Science ®Google Scholar
• Wang L, Li J, Chen H et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull. World Health Organ.85(9), 688–694 (2007).
   PubMed Web of Science ®Google Scholar
• Otto BF, Suarnawa IM, Stewart T et al. At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. Vaccine18(5–6), 498–502 (1999).
   PubMed Web of Science ®Google Scholar
• Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull. World Health Organ.77(1), 119–126 (1999).
   PubMed Web of Science ®Google Scholar
• Hipgrave DB, Tran TN, Huong VM et al. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. Am. J. Trop. Med. Hyg.74(2), 255–260 (2006).
   PubMed Web of Science ®Google Scholar
• Just M, Berger R. Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine. Vaccine6(5), 399–400 (1988).
   PubMed Web of Science ®Google Scholar
• Schöndorf I, Banzhoff A, Nicolay U, Diaz-Mitoma F. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: a controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of menjugate, stored at room temperature for 6 months. Vaccine25(7), 1175–1182 (2007).
   PubMed Web of Science ®Google Scholar
• Ho MM, Mawas F, Bolgiano B et al. Physico–chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines. Vaccine20(29–30), 3509–3522 (2002).
   PubMed Web of Science ®Google Scholar
• Shank-Retzlaff ML, Zhao Q, Anderson C et al. Evaluation of the thermal stability of gardasil. Hum. Vacc.2(4), 147–154 (2006).
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev. Vaccines7(3), 345–353 (2008).
   PubMed Web of Science ®Google Scholar
• Maa Y, Ameri M, Shu C, Payne LG, Chen D. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J. Pharm. Sci.93(7), 1912–1923 (2004).
   PubMed Web of Science ®Google Scholar
• Amorij J, Meulenaar J, Hinrichs WLJ et al. Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying. Vaccine25(35), 6447–6457 (2007).
   PubMed Web of Science ®Google Scholar
• Burger JL, Cape SP, Braun CS et al. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine. J. Aerosol. Med.21(1), 25–34 (2008).
   Google Scholar